CSLLY
CSL LTD-SPON ADR
Health Care·Biotechnology·AUSTRALIA
$31.56
MCap $60.5B
as of 2026-09-04
Total
C1w
Fund
E2w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.38
Sentiment 78.1%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$31.56
Adaptive Mean
$32.31
-0.75 vs mean
Adaptive σ
0.99
MIDOS BB
$30.33 – $34.30
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.48
ROE
-15.8%
Z +0.37
Rev Gr
5.5%
Z —
EPS Gr
—
Z —
OPM Gr
—
Z —
FCF Yld
3.1%
Z +0.59
EPS Surp
—
Z —
EPS 3mo Δ
—
Z —
Fwd P/E
18.12
Z —
PEGY
0.08
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
30.37
Q6M
5.63
Q12M
-1.21
MA 30/100
1.201
Bullish (MA30 > MA100)
α (Jensen)
2.5025
β (12M)
0.45
σ (12M)
0.423
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
92%
Q Percentile
37%
Divergence
+55.0
Tier
RELOAD — ACT
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
13.2
RS Pctl
77%
RS Decile
D8
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.